Medicare's $2,000 prescription drug cap expected to bring major relief to cancer patients
The new price cap, part of the Inflation Reduction Act, will apply to all prescription drugs covered by Medicare.
MedPage Today2d
In Settling Fraud Case, N.Y. Medicare Advantage Insurer, CEO Will Pay Up to $100M
A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total ...
Medicare's new $2,000 prescription drug cap goes into effect Jan. 1. Here's how it works.
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
Medpage Today on MSN3d
Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
In advancing the 2.83% cut, Congress ignored the recommendation from the Medicare Payment Advisory Commission (MedPAC) to ...
Medicare to Change if Spending Bill Passes: Here's How
The Continuing Appropriations and Disaster Relief Supplemental Appropriations Act would make changes to Medicare for 2025.
Medicare prescription drug cap set to take effect Jan. 1
The changes to Medicare’s prescription drug cap were set in motion by the Biden administration’s 2022 Inflation Reduction Act ...
Medicare's $2,000 prescription drug cap set to ease costs for cancer patients
Medicare recipients will see a major change as out-of-pocket prescription drug costs are capped at $2,000 per year under the ...
New Medicare rules to cap prescription drug costs for seniors
Medicare recipients will see a $2,000 out-of-pocket cap on some prescription drugs as part of several new provisions coming ...
JD Supra11h
The Medicare Advantage Program: Public Money & Private Insurance Companies
When I investigated and litigated False Claims Act (FCA) cases at the U.S. Department of Justice (DOJ) over the last 10 years ...
WHTM Harrisburg on MSN19h
Carlisle couple scammed by Medicare employee impersonator
A Cumberland County couple was allegedly scammed by a person posing as a medicare employee. According to Pennsylvania State ...
Shilpa Medicare's Unit IV and Unit VII secures Eurasia GMP approval
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval of Eurasia, the member countries for which are Belarus, Russia, Kazakhstan, Kyrgyzstan and Armenia.
Medicare Advantage Home Visits Face Increased Scrutiny
A federal watchdog calls for tighter control over Medicare Advantage home visits. Here's how it could impact taxpayers.